Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF), a clinical-stage pharma company focused on photo-dynamic compounds, has donated two of its pioneering TLC-2400 Cool Laser Therapy (CLT) systems to the University of Windsor to aid the search for a breakthrough in Parkinson's disease.
In a collaborative effort with the Faculty of Human Kinetics and a local chiropractor, Theralase is embarking on a groundbreaking clinical study to investigate the efficacy of its CLT technology when used to treat the neuro-degenerative disorder.
Theralase's CLT employs super-pulsed laser technology capable of non-invasively penetrating the human skull, stimulating neurons, and promoting anti-inflammatory responses.
"The initiation of the first randomized placebo-controlled study on laser light therapy for Parkinson's patients marks a pivotal moment in our quest to find more effective treatments for this debilitating disease," stated Anthony Bain, a kinesiology professor at the university and the person leading the clinical study.
Preliminary investigations and animal studies into CLT's application in Parkinson's disease have yielded encouraging results, suggesting potential enhancements in motor function and a notable diminishment in disease symptoms.
Parkinson's disease, characterized by tremors, mobility challenges, and a host of non-motor impairments, affects approximately one million individuals across North America and 10 million globally.
The financial toll of Parkinson's disease on the US economy is staggering, with annual direct medical costs amounting to approximately $25.4 billion, alongside an additional $26.5 billion incurred through lost work, wages, and caregiver expenses.
As mentioned above, the clinical study is designed as a double-blind randomized controlled trial, which aims to eliminate bias and scientifically ascertain the impact of Theralase's CLT on Parkinson's disease.
"This clinical data will allow us to scientifically and clinically determine the impact that Theralase CLT is making on this deadly disease," explained Windsor's Bain.